{"id": "1602959364389670912", "text": "$abbv  $45,00 a day keeps the 9 to 5 away; For a limited time, we are opening our trading chat-room to the public&gt;~ ---&gt;\ud83d\ude80\nhttps://t.co/PArt1eChRp", "author_id": "1591390471896502272", "edit_history_tweet_ids": ["1602959364389670912"], "created_at": "2022-12-14T09:31:08.000Z"}
{"text": "RT @DarthDividend23: Dividend Growth Stocks \n\n$O Realty Income\n$JPM JP Morgan &amp; Chase Co\n$AMT American Tower\n$KO Coca-Cola\n$PG Proctor &amp; Ga\u2026", "id": "1603112654297780225", "author_id": "2338415944", "edit_history_tweet_ids": ["1603112654297780225"], "created_at": "2022-12-14T19:40:15.000Z"}
{"text": "$ABBV \"Top analyst price target for next week ---&gt;\ud83d\ude80\nhttps://t.co/B3lNVj57HD", "id": "1603147005530099712", "author_id": "1584170027976384512", "edit_history_tweet_ids": ["1603147005530099712"], "created_at": "2022-12-14T21:56:45.000Z"}
{"text": "We are glad to help this member reach his goal. Check out what he said in his updated review of our server https://t.co/hGrNzgF56J\n\n$CMCSA $PEP $SAP $XOM $ABBV $ABT $TM $CRM $ORCL $CVX $ASML $LLY $TMO $AMGN $AZN $NKECHL $COST $MCD $ACN $BMY $DHR $NEE $SNY $CHTR $MDT $TMUS https://t.co/E4w81JHaf0", "id": "1603125230557347840", "author_id": "1600941741951307776", "edit_history_tweet_ids": ["1603125230557347840"], "created_at": "2022-12-14T20:30:14.000Z"}
{"text": "$ABBV   Top analyst price target for next week\n https://t.co/B3lNVj57HD", "id": "1603091239506964480", "author_id": "1584170027976384512", "edit_history_tweet_ids": ["1603091239506964480"], "created_at": "2022-12-14T18:15:10.000Z"}
{"id": "1603027692500271107", "text": "Trending: Pharmaceutical\n\n$QTRX -0.73 %\n$LLY 0.78 %\n$HROW 8.11 %\n$OBSV 8.30 %\n$PFE 0.34 %\n$ABBV 0.00 %\n$HAPP 3.00 %\n$NRBO 0.61 %\n$JAGX 4.58 %\n$MRK -0.37 %\n\nhttps://t.co/WV3qS0l6fi", "author_id": "1448619461892771843", "edit_history_tweet_ids": ["1603027692500271107"], "created_at": "2022-12-14T14:02:39.000Z"}
{"id": "1603020732618907653", "text": "\"Exicure says development collaborations with AbbVie, Ipsen terminated\" via @SeekingAlpha\n\nTrending #abbvieinc news with frequent shares and strong engagement across social media.\n\nSocial Insights: https://t.co/PQszB5Snnr $abbv\n\nSource\ud83d\udc47https://t.co/RGymVWbw3W", "author_id": "1364205368411385860", "edit_history_tweet_ids": ["1603020732618907653"], "created_at": "2022-12-14T13:34:59.000Z"}
